Under the lens
Analysing how longer leases are delivering secure income and driving the appeal of European life sciences
7 min read
Occupier insights
Gain valuable occupier insights into the life sciences real estate market. Discover trends in tenant demand, leasing strategies, and the evolving needs of biotech and pharma companies.
7 posts
paid
How funding drives headcount and demand for R&D space
Our analysis shows that every €1 billion in life sciences funding drives demand over time for c.17,000 square metres of R&D space
6 min read
paid
How life science leases compare to other sectors
We compare the lease length of different sectors to our proprietary database of life sciences deals.
7 min read
paid
Maximising the value of corporate real estate in the pharma sector
To maximise the value of their enormous real estate portfolios, pharma companies have two key strategies: continuous portfolio optimisation and capital unlocking through sale and leaseback (S&LB) transactions.
5 min read
paid
Cloud labs: can remote research fix the shortage of lab space?
Cloud laboratories enable scientists to run experiments remotely without the need for physical presence and could ease the shortage of lab space.
7 min read
paid
From lab to jab: the real estate backbone of pharmaceutical distribution
Each step of the journey "from lab to jab" requires a specific type of premises.
8 min read